Sec. 565.055. INVESTIGATION; CONFIDENTIALITY OF INFORMATION  


Latest version.
  • (a) The board or the board's authorized representative may investigate and gather evidence concerning any alleged violation of this subtitle or a board rule.

    (b) Information or material compiled by the board in connection with an investigation, including an investigative file of the board, is confidential and not subject to:

    (1) disclosure under Chapter 552, Government Code; or

    (2) any means of legal compulsion for release, including disclosure, discovery, or subpoena, to anyone other than the board or a board employee or board agent involved in discipline of a license holder.

    (c) Notwithstanding Subsection (b), information or material compiled by the board in connection with an investigation may be disclosed:

    (1) during any proceeding conducted by the State Office of Administrative Hearings, to the board, or a panel of the board, or in a subsequent trial or appeal of a board action or order;

    (2) to a person providing a service to the board, including an expert witness, investigator, or employee of an entity that contracts with the board, related to a disciplinary proceeding against an applicant or license holder, or a subsequent trial or appeal, if the information is necessary for preparation for, or a presentation in, the proceeding;

    (3) to an entity in another jurisdiction that licenses or disciplines pharmacists or pharmacies;

    (4) to a pharmaceutical or pharmacy peer review committee as described under Chapter 564;

    (5) to a law enforcement agency;

    (6) to a person engaged in bona fide research, if all information identifying a specific individual has been deleted; or

    (7) under a court order.

Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999. Amended by Acts 2001, 77th Leg., ch. 1420, Sec. 14.311(a), eff. Sept. 1, 2001. Amended by: Acts 2011, 82nd Leg., R.S., Ch. 923 , Sec. 6, eff. June 17, 2011.